Baxter International (BAX) PEG Ratio: History & Chart

Baxter International Inc. (BAX)BAXBaxter International Inc.

About Baxter International Inc.

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.

Deerfield, IL

37,500 employees

www.baxter.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Andrew Hider

View full financials

NAME	MARKET CAP	PEG RATIO	TTM	3Y	5Y
Baxter International Inc. (BAX)	$13.52B	N/A	N/A	0.70	1.43
The Cooper Companies, Inc. (COO)vs ›	$14.10B	N/A	1.65	0.82	0.56
Revvity, Inc. (RVTY)vs ›	$12.55B	N/A	0.95	0.69	0.60
Solventum Corporation (SOLV)vs ›	$14.80B	0.04	0.04	117.61	78.52
Align Technology, Inc. (ALGN)vs ›	$12.11B	51.77	51.77	26.79	17.89
DaVita Inc. (DVA)vs ›	$15.41B	2.93	0.38	0.35	0.56
Insulet Corp. (PODD)vs ›	$11.45B	0.38	0.23	2.94	3.14
Bio-Techne Corporation (TECH)vs ›	$11.29B	N/A	5.16	3.55	2.84
Charles River Laboratories International, Inc. (CRL)vs ›	$11.20B	N/A	0.05	0.52	2.58
Medpace Holdings, Inc. (MEDP)vs ›	$16.11B	1.82	1.22	1.14	1.18

NAME

MARKET CAP

PEG RATIO

TTM

Baxter International Inc. (BAX)

$13.52B

N/A

0.70

1.43

The Cooper Companies, Inc. (COO)vs ›

$14.10B

N/A

1.65

0.82

0.56

Revvity, Inc. (RVTY)vs ›

$12.55B

N/A

0.95

0.69

0.60

Solventum Corporation (SOLV)vs ›

$14.80B

0.04

117.61

78.52

Align Technology, Inc. (ALGN)vs ›

$12.11B

51.77

26.79

17.89

DaVita Inc. (DVA)vs ›

$15.41B

2.93

0.38

0.35

0.56

Insulet Corp. (PODD)vs ›

$11.45B

0.38

0.23

2.94

3.14

Bio-Techne Corporation (TECH)vs ›

$11.29B

N/A

5.16

3.55

2.84

Charles River Laboratories International, Inc. (CRL)vs ›

$11.20B

N/A

0.05

0.52

2.58

Medpace Holdings, Inc. (MEDP)vs ›

$16.11B

1.82

1.22

1.14

1.18

PEG Ratio FAQ

What is the PEG ratio for Baxter International Inc. (BAX)?

The PEG ratio for BAX stock is N/A.

What is the 3Y average PEG ratio for Baxter International Inc. (BAX)?

The 3Y average PEG ratio for BAX stock is 0.70.

What is the 5Y average PEG ratio for Baxter International Inc. (BAX)?

The 5Y average PEG ratio for BAX stock is 1.43.

What is the 10Y average PEG ratio for Baxter International Inc. (BAX)?

The 10Y average PEG ratio for BAX stock is 0.89.

What is the 15Y average PEG ratio for Baxter International Inc. (BAX)?

The 15Y average PEG ratio for BAX stock is 0.81.

What is the 20Y average PEG ratio for Baxter International Inc. (BAX)?

The 20Y average PEG ratio for BAX stock is 0.33.

DATE	PEG RATIO
2024-12-31	0.18
2022-12-31	0.04
2021-12-31	1.87
2020-12-31	3.64
2018-12-31	0.12
2016-12-31	0.01
2014-12-31	0.35
2012-12-31	1.08
2011-12-31	0.11
2009-12-31	0.69
2008-12-31	0.42
2007-12-31	0.51
2006-12-31	0.30
2005-12-31	0.09
2002-12-31	0.17
1999-12-31	0.08
1998-12-31	8.06
1996-12-31	2.04

DATE

PEG RATIO

2024-12-31

0.18

2022-12-31

0.04

2021-12-31

1.87

2020-12-31

3.64

2018-12-31

0.12

2016-12-31

0.01

2014-12-31

0.35

2012-12-31

1.08

2011-12-31

0.11

2009-12-31

0.69

2008-12-31

0.42

2007-12-31

0.51

2006-12-31

0.30

2005-12-31

0.09

2002-12-31

0.17

1999-12-31

0.08

1998-12-31

8.06

1996-12-31

2.04

PEG Ratio: N/A

BAX PEG Ratio Chart

BAX Average PEG Ratio Chart

BAX PEG Ratio Metrics

BAX Competitors' PEG Ratio

Growth-Adjusted Valuation

PEG Ratio Formula & Definition

PEG Ratio FAQ

BAX PEG Ratio History

Related Metrics